Bajaj Healthcare Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: BAJAJHCARE BSE: 539872

₹319.10

Oct. 5, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #90 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	427,010	143.5	13.7%	7.6%	—	72	8	30
Divi's Laboratories Limited	244,125	83.0	15.3%	57.8%	0.33%	70	4	51
Torrent Pharmaceuticals Limited	161,506	77.7	12.2%	35.3%	0.80%	56	0	31
Zydus Lifesciences Limited	113,616	32.6	17.3%	14.5%	0.09%	74	24	84
Cipla Limited	107,888	35.1	11.2%	-11.7%	0.97%	73	29	62
Laurus Labs Limited	106,505	122.0	17.1%	128.4%	—	78	24	53
Mankind Pharma Limited	102,382	46.9	11.7%	0.9%	—	68	12	86
Dr. Reddy's Laboratories Limited	100,411	150.9	10.9%	-3.7%	—	62	33	71
Bajaj Healthcare Limited (this stock)	1,074	44.9	8.1%	-34.4%	0.47%	46	39	15

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹1,270 Cr

EV / EBITDA

15.3x

EV / Sales

2.02x

Market cap / Sales

1.71x

Earnings yield

2.23%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 166 Cr, up 11.2% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	166	16	14	₹4.1300
March 31, 2026	153	-21	-23	₹-6.0800
Dec. 31, 2025	161	19	16	₹5.1000
Sept. 30, 2025	148	16	11	₹3.9500
June 30, 2025	149	15	12	₹3.8500
March 31, 2025	154	12	11	₹3.6700
Dec. 31, 2024	123	12	12	₹4.6600
Sept. 30, 2024	133	12	9	₹2.9600
June 30, 2024	132	10	7	₹2.9080
March 31, 2024	134	-35	-30	₹-11.5900
Dec. 31, 2023	109	6	-2	₹2.0000
Sept. 30, 2023	101	5	-3	₹1.8600
June 30, 2023	130	7	-48	₹2.5500

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	166	156	163	150	150	168	125	136	133	140	109	102	130
Operating revenue	166	153	161	148	149	154	123	133	132	134	109	101	130
Other income	1	3	2	2	1	14	2	3	1	6	1	1	0
Operating expenses	137	130	131	121	124	143	101	109	108	118	89	82	108
Operating profit	29	23	31	27	25	12	22	25	25	16	20	19	22
Operating profit margin	17.4%	14.8%	19.0%	18.2%	16.5%	7.6%	17.6%	18.4%	18.5%	12.0%	18.0%	18.7%	16.8%
Depreciation	7	8	7	7	6	8	7	7	7	7	7	7	6
Interest	6	6	6	6	5	6	6	8	8	6	7	8	9
Exceptional items, gain / (loss)	—	-33	—	—	—	—	—	—	—	-44	—	—	—
Profit before tax	16	-21	19	16	15	12	12	12	10	-35	6	5	7
Tax	3	-1	3	4	2	0	-3	4	2	-3	1	0	-0
Net profit	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS	4.13	-6.08	5.10	3.95	3.85	3.67	4.66	2.96	2.91	-11.59	2.00	1.86	2.55
Net profit (TTM)	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS (TTM)	7.10	6.82	16.57	16.13	15.14	14.20	-1.06	-3.72	-4.82	-5.18	7.71	9.72	13.79

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	611	29	16
March 31, 2025	543	46	39
March 31, 2024	473	-17	-84
March 31, 2023	673	58	43

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Total income (before exceptional items)	-2.9%	-1.4%	618^†	562^†	482^†	675^†	681^†	664^†	414^†
Operating revenue	-3.2%	-1.4%	611	543	473	673	680^†	657^†	410^†
Other income	—	—	7^†	19^†	9^†	2^†	1^†	7^†	4^†
Operating expenses	—	—	506^†	460^†	397^†	566^†	561^†	521^†	362^†
Operating profit	-0.6%	-5.1%	105^†	82^†	76^†	107^†	119^†	136^†	48^†
Operating profit margin	—	—	17.2%^†	15.2%^†	16.1%^†	15.9%^†	17.4%^†	20.8%^†	11.6%^†
Depreciation	—	—	28^†	28^†	28^†	27^†	18^†	16^†	12^†
Interest	—	—	22^†	28^†	30^†	23^†	13^†	8^†	6^†
Exceptional items, gain / (loss)	—	—	-33^†	0^†	-44^†	0^†	0^†	0^†	0^†
Profit before tax	-20.8%	-24.6%	29	46	-17	58	90^†	119^†	32^†
Tax	—	—	8^†	3^†	-2^†	15^†	18^†	36^†	10^†
Net profit	-28.4%	-28.3%	16	39	-84	43	71^†	83^†	22^†
EPS	-24.1%	-35.3%	6.82^†	14.20^†	-5.18^†	15.59^†	32.83^†	60.23^†	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Operating margin	17.2%^†	15.2%^†	16.1%^†	15.9%^†	17.4%^†	20.8%^†	11.6%^†
EBIT margin	8.4%^†	13.6%^†	2.7%^†	12.0%^†	15.0%^†	19.3%^†	9.5%^†
PBT margin	4.7%	8.5%	-3.5%	8.6%	13.2%^†	18.1%^†	7.9%^†
Net margin	2.6%	7.3%	-17.7%	6.4%	10.5%^†	12.7%^†	5.5%^†
Interest coverage	2.30x^†	2.65x^†	0.44x^†	3.55x^†	8.10x^†	15.32x^†	6.03x^†
Dividend payout	14.7%^†	7.0%^†	—	9.6%^†	0.0%^†	0.0%^†	—
Earnings retention	85.3%^†	93.0%^†	—	90.4%^†	100.0%^†	100.0%^†	—
Current ratio	1.78x	1.78x	—	—	—	—	—
Quick ratio	1.10x	1.19x	—	—	—	—	—
Debt to equity	0.44x	0.48x	—	—	—	—	—
Return on equity	3.0%	8.5%	—	—	—	—	—
Return on assets	1.7%	4.7%	—	—	—	—	—
Return on capital employed	8.5%^†	13.2%^†	—	—	—	—	—
Asset turnover	0.66x	0.65x	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	58	-48	24	43	15
March 31, 2025	22	-15	-6	12	10
March 31, 2024	92	-11	-97	30	62
March 31, 2023	-22	-93	131	94	-116
March 31, 2022	1	-75	62	74	-74

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	923	533	516	186	48	569	320	37	247	216
March 31, 2025	833	466	450	158	65	485	272	3	237	162
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.